Abstract:Abstract Diffuse glioma exhibit an immunosuppressive microenvironment, yet glioma subsets driven by RAF-alterations exhibit an increased immune signature. In pleomorphic xanthoastrocytoma (PXA), we identified CXCL14 as an important factor promoting a cytotoxic T cell response. The molecular and spatial relationships within this tumor type, however, are unknown. To address this, we use single nucleus RNA sequencing (snRNAseq), spatial transcriptomics, and spatial molecular imaging to construct a high-resolution molecular landscape of PXA. SnRNAseq was performed on 36,781 cells from 10 tumors, including initial and recurrent pairs, spatial transcriptomes were performed on a total of 91 FOVs comprised of 17 PXAs, and spatial molecular imaging (SMI) of 1,000 RNA probes at subcellular resolution was performed on 48,518 cells from 6 tumors, including two PXA, two pilocytic astrocytoma, and two ganglioglioma. For snRNAseq, neoplastic cells were separated from non-malignant cells based on analysis of inferred copy number alterations. CellChat was used to infer cell-cell communication. For spatial transcriptomics, data from 200-300μm FOVs were normalized and divided into CD3-high versus CD3-low groups. For SMI, cells with fewer than 20 transcripts were eliminated, data were normalized using simple total counts, cells were segmented using the Nanostring pipeline, and semi-supervised clustering was performed. Dual CXCL14 RNAscope and Iba1/CD3 immunostaining confirmed spatial relationships within the tumor. In PXA with high-CD3, differential gene expression analysis demonstrated broad immune-enrichment and identified upregulation of several ligand-receptor pairs. Integrating these data with snRNAseq and cell-cell communication analysis inferred paracrine interactions between tumor cells and T cells. One such factor, CXCL14, was expressed widely by tumor cells but spatial analysis revealed cohesive clusters of CXCL14-high expressing tumor cells. In anaplastic (CNS WHO grade 3) tumors, however, both CXCL14 expression and microglia decreased. These high-resolution molecular analyses of PXA identify dynamic tumor-immune crosstalk regulating the immune microenvironment.

Molecular Features of Pleomorphic Xanthoastrocytoma.

Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma

Clinicopathological, Morphological and Molecular study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma

BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study

Analysis of Comparative Genomic Hybridization in Pleomorphic Xanthoastrocytoma

Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, and Epithelioid Glioblastoma: Case Series with Clinical Characteristics, Molecular Features and Progression Relationship

Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma

MRI analysis of pleomorphic xanthoastrocytoma

Anaplastic Pleomorphic Xanthoastrocytoma with Disseminated Growth Pattern at the Time of Diagnosis As Well As after Treatment: Case Report and Review of Literature

Clinical Manifestations And Outcomes Of Typical Versus Atypical Pleomorphic Xanthoastrocytoma: A Single-Institution Experience

Molecular Characterization of Clinically Defined Aggressive Variant Prostate Cancer (avpca) in Prospectively Collected Tissues and Corresponding Patient Derived Xenografts (PDX).

Clinicopathologic study of pleomorphic xanthoastrocytoma and giant cell glioblastoma

Infratentorial Pleomorphic Xanthoastrocytoma: Report Of Two Cases And Review Of Literature

Pleomorphic xanthoastrocytoma with NTRK fusion presenting as spontaneous intracranial hemorrhage-case report and literature review

TMIC-83. THE MOLECULAR AND SPATIAL ARCHITECTURE OF AN IMMUNE-RICH GLIOMA SUBTYPE

Pleomorphic Xanthoastrocytoma:Imaging Findings and Pathology Correlation

Xenotransplantation of Pediatric Low Grade Gliomas Confirms the Enrichment of BRAF V600E Mutation and Preservation of CDKN2A Deletion in a Novel Orthotopic Xenograft Mouse Model of Progressive Pleomorphic Xanthoastrocytoma

Exploring prognostic factors and treatment strategies for long-term survival in pleomorphic xanthoastrocytoma patients

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging

Surg-02. Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination Presenting With Cranial Neuropathy In An Adult Patient: Illustrative Case And Review Of The Literature